FIELD: medicine; gynecology.
SUBSTANCE: invention can be used to determine the risk of recurrence of endometrioid ovarian cysts after surgical treatment. The following anamnestic indicators are determined: age, presence of chronic pelvic pain, presence of adenomyosis, height, weight, body mass index and laboratory indicator — CA-125 level. Then the prognostic index of endometriosis recurrence (IRE) is calculated using the author’s formula. And if IREN is ≥1.93 a high risk of recurrence of endometrioid ovarian cysts is predicted, if IREN is <1.93, the risk of recurrence is low.
EFFECT: method allows to reduce the likelihood of relapse of ovarian endometriosis after surgical treatment by prescribing hormonal therapy, by determining the assessment of the totality of the most significant indicators.
1 cl, 2 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RECURRENT ENDOMETRIOID OVARIAN CYSTS | 2018 |
|
RU2694882C1 |
| METHOD FOR PERSONALISED TREATMENT OF OVARIAN ENDOMETRIOSIS IN WOMEN OF REPRODUCTIVE AGE BASED ON A POINT DIAGNOSTIC SYSTEM | 2021 |
|
RU2761982C1 |
| METHOD FOR PREDICTING A DECREASE IN OVARIAN RESERVE IN PATIENTS OF REPRODUCTIVE AGE AFTER SURGICAL TREATMENT OF DEEP INFILTRATIVE ENDOMETRIOSIS | 2022 |
|
RU2775543C1 |
| METHOD FOR PREDICTING RECURRENCE OF ENDOMETRIOID OVARIAN CYSTS AFTER SURGICAL TREATMENT | 2021 |
|
RU2757236C1 |
| METHOD FOR PREDICTION OF POSTOPERATIVE FERTILITY RECOVERY IN FEMALES WITH ENDOMETRIOSIS GENITALIS EXTERNA | 2013 |
|
RU2523556C1 |
| METHOD FOR DIAGNOSTICS OF MINOR FORMS OF ENDOMETRIOSIS | 2020 |
|
RU2749290C1 |
| METHOD FOR EARLY DIAGNOSIS OF NEOPLASTIC TRANSFORMATION OF ENDOMETRIOID OVARIAN CYSTS | 2020 |
|
RU2730952C1 |
| METHOD FOR INTEGRATED TREATMENT OF EXTERNAL GENITAL ENDOMETRIOSIS | 2013 |
|
RU2541089C1 |
| METHOD FOR CYSTECTOMY IN CASE OF OVARIAN ENDOMETRIOSIS AND INFERTILITY IN WOMEN OF REPRODUCTIVE AGE | 2020 |
|
RU2750276C1 |
| METHOD FOR PREDICTING THE RECURRENCE OF ENDOMETRIAL CYSTS AFTER SURGICAL TREATMENT BY MEANS OF IMMUNOHISTOCHEMICAL MARKERS | 2017 |
|
RU2681219C1 |
